Five Prime Therapeutics, Inc. Announces Closing of Initial Public Offering

Published: Sep 24, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime) announced today the closing of its initial public offering of 4,800,000 shares, resulting in aggregate gross proceeds of $62.4 million, before underwriting discounts, commissions and expenses. All of such shares were sold by Five Prime at an initial offering price of $13.00 per share.

Help employers find you! Check out all the jobs and post your resume.

Back to news